Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-05T12:08:12.416Z Has data issue: false hasContentIssue false

Antibodies against somatic antigens and excreted/secreted products of Brugia pahangi in rats with patent and non-patent infections

Published online by Cambridge University Press:  06 April 2009

C. Fletcher
Affiliation:
Department of Parasitology, National Yang-Ming Medical College, Shihpai, Taipei 11221, Taiwan, R.O.C.
C. C. Wu
Affiliation:
Department of Parasitology, National Yang-Ming Medical College, Shihpai, Taipei 11221, Taiwan, R.O.C.

Summary

The humoral responses of Sprague–Dawley rats infected with Brugia pahangi were examined for up to 6 months after infection by ELISA, immunoblotting, and IFAT. In 2 experiments, 50% and 62·5% of rats developed patent, microfilaraemic infections. Mean adult worm burdens at autopsy were approximately 2% of the inoculum, and only patent rats yielded living adult worms. IgG antibody levels against crude somatic extracts (CSE) of all parasite stages and against adult excreted/secreted (ES) products were significantly higher in patent than non-patent rats. Both patent and non-patent rats produced anti-microfilarial surface antibody, as revealed by immunofluorescence. Immunostaining of Western blots by early infection sera showed no consistent difference in recognition of infective larval (L3) antigenic components by IgG or IgM antibody between eventually-patent and eventually-non-patent rats. By 26 weeks, however, patent rats recognized more components. The data suggest that antibodies against L3, adult, and microfilarial somatic antigens, ES antigens and microfilarial surface antigens do not correlate with the subsequent development of microfilaraemia in any individual rat.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Carlow, C. K. S. & Philipp, M. (1987). Protective immunity to Brugia malayi larvae in Balb/c mice: potential of this model for the identification of protective antigens. American Journal of Tropical Medicine and Hygiene 37, 597604.CrossRefGoogle ScholarPubMed
Chandrashekar, R., Rao, U. R. & Subramanyam, D. (1990). Antibody-mediated cytotoxic effects in vitro and in vivo of rat cells on infective larvae of Brugia malayi. International Journal for Parasitology 20, 725–30.CrossRefGoogle ScholarPubMed
Chusattayanond, W. & Denham, D. A. (1986). Attempted vaccination of jirds (Meriones unguiculatus) against Brugia pahangi with radiation attenuated infective larvae. Journal of Helminthology 60, 149–55.Google Scholar
Cruickshank, J. K., Price, K. M., Mackenzie, C. D., Spry, C. J. F. & Denham, D. A. (1983). Infection of inbred and nude (athymic) rats with Brugia spp. Parasite Immunology 5, 527–37.CrossRefGoogle ScholarPubMed
Day, K. P., Gregory, W. F. & Maizels, R. M. (1991). Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunology 13, 277–90.Google Scholar
Denham, D. A., Dennis, D. T., Ponnudurai, T., Nelson, G. S. & Guy, F. (1971). Comparison of a counting chamber and thick smear methods of counting microfilariae. Transactions of the Royal Society of Tropical Medicine and Hygiene 65, 521.CrossRefGoogle ScholarPubMed
Denham, D. A. & Fletcher, C. (1987). The cat infected with Brugia pahangi as a model of human lymphatic filariasis. Ciba Foundation Symposium 127, Filariasis, pp. 225230. Chichester: John Wiley.Google Scholar
Fletcher, C., Birch, D. W. & Denham, D. A. (1992). Cats with single Brugia pahangi infections: relationship between parasitological status and humoral responses to somatic and surface parasite antigens. Parasite Immunology (in the Press).CrossRefGoogle ScholarPubMed
Fletcher, C., Birch, D. W., Samad, R. & Denham, D. A. (1986). Brugia pahangi infections in cats: antibody responses which correlate with the change from the microfilaraemic to the amicrofilaraemic state. Parasite Immunology 8, 345–57.Google Scholar
Fox, E. G. & Schacher, J. F. (1976). A comparison of syngeneic laboratory rat strains as hosts for Brugia pahangi. Transactions of the Royal Society of Tropical Medicine and Hygiene 70, 532.CrossRefGoogle ScholarPubMed
Grenfell, B. T., Michael, E. & Denham, D. A. (1991). A model for the dynamics of human lymphatic filariasis. Parasitology Today 7, 318–23.CrossRefGoogle Scholar
Gusmao, R., D'A Stanley, A. M. & Ottesen, E. A. (1981). Brugia pahangi: immunologic evaluation of the differential susceptibility to filarial infection in inbred Lewis rats. Experimental Parasitology 52, 147–59.Google Scholar
Ho, C. M., Chen, C. C. & Wu, C. C. (1987). Peripheral microfilaraemia and eosinophilia in rats infected with Brugia pahangi. Proceedings of 1st Sino-American Symposium on Biotechnology and Parasitic Diseases, Taipei, pp. 109114.Google Scholar
Kazura, J. W., Cicirello, H. & Mccall, J. W. (1986). Induction of protection against Brugia malayi infection in jirds by microfilarial antigens. Journal of Immunology 136, 1422–6.CrossRefGoogle ScholarPubMed
Kazura, J. W. & Davies, R. S. (1982). Soluble Brugia malayi microfilarial antigens protect mice against challenge by an antibody-dependent mechanism. Journal of Immunology 128, 1792–6.CrossRefGoogle ScholarPubMed
Klei, T. R., Enright, F., Mcdonough, K. & Coleman, S. V. (1988). Brugia pahangi; granulomatous lesion development in jirds following single and multiple infections. Experimental Parasitology 66, 132–9.Google Scholar
Kwan-Lim, G. E., Gregory, W. F., Selkirk, M. E., Partono, F. & Maizels, R. M. (1989). Secreted antigens of filarial nematodes: a survey and characterization of in vitro excreted/secreted products of Brugia malayi. Parasite Immunology 11, 629–54.CrossRefGoogle ScholarPubMed
Lawrence, R. & Denham, D. A. (1991). Brugia pahangi in rats: increasing the number of infective larvae inoculated increases the percentage of microfilaraemic rats. Journal of Parasitology 77, 173–5.CrossRefGoogle Scholar
Maizels, R. M., Denham, D. A. & Sutanto, I. (1985). Secreted and circulating antigens of the filarial nematode parasite Brugia pahangi: analysis of in vitro released components and detection of parasite products in vivo. Molecular and Biochemical Parasitology 17, 277–88.CrossRefGoogle ScholarPubMed
Maizels, R. M., Gregory, W. F., KWAN-Lim, G. E. & Selkirk, M. E. (1989). Filarial surface antigens: the major 29 kilodalton glycoprotein and a novel 17–200 kilodalton complex from adult Brugia malayi parasites. Molecular and Biochemical Parasitology 32, 213–28.Google Scholar
Maizels, R. M. & Lawrence, R. A. (1991). Immunological tolerance: the key feature in human filariasis? Parasitology Today 7, 271–6.Google Scholar
Oothuman, P., Denham, D. A., Mcgreevey, P. M., Nelson, G. S. & Rogers, R. (1979). Successful vaccination of cats against Brugia pahangi with larvae attenuated by irradiation with 10 Krad cobalt 60. Parasite Immunology 1, 209–16.CrossRefGoogle ScholarPubMed
Vickery, A. C. & Vincent, A. L. (1984). Immunity to Brugia pahangi in athymic nude and normal mice: eosinophilia, antibody and hypersensitivity responses. Parasite Immunology 6, 545–59.CrossRefGoogle ScholarPubMed
Vincent, A. L. & Vickery, A. C. (1983). Brugia pahangi antibodies and microfilaremias in Lewis rats. Experimental Parasitology 56, 381–90.CrossRefGoogle ScholarPubMed
Weller, P. F. (1978). Cell-mediated immunity in experimental filariasis: lymphocyte reactivity to filarial stage-specific antigens and to B- and T-cell mitogens during acute and chronic infection. Cellular Immunology 37, 369–82.Google Scholar